Ticker Symbol | Entity Name | As Of Date | Company Name | Followers | Employees on Linkedin | Link | Industry | Date Added | Date Updated | Description | Website | Specialities | Logo | HQ.Street | HQ.City | HQ.State | HQ.Country | HQ.Postal | Headcount change in past 24 months | Company Name | Sector | Industry |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
private:entasistx | 6453563 | Nov 18th, 2019 12:00AM | Entasis Therapeutics | 1.4K | 54.00 | Open | Biotechnology | Nov 18th, 2019 04:13PM | Nov 18th, 2019 04:13PM | Entasis Therapeutics is developing a portfolio of innovative cures for serious drug-resistant bacterial infections, a global health crisis affecting the lives of millions of patients. Our deep pipeline of novel clinical and preclinical antibacterial programs is designed to revolutionize the way physicians treat serious bacterial diseases. | Open | Open | 35 Gatehouse Drive | Waltham | MA | US | 02451 | Entasis Therapeutics | ||||
private:entasistx | 6453563 | Nov 17th, 2019 12:00AM | Entasis Therapeutics | 1.4K | 54.00 | Open | Biotechnology | Nov 17th, 2019 04:38PM | Nov 17th, 2019 04:38PM | Entasis Therapeutics is developing a portfolio of innovative cures for serious drug-resistant bacterial infections, a global health crisis affecting the lives of millions of patients. Our deep pipeline of novel clinical and preclinical antibacterial programs is designed to revolutionize the way physicians treat serious bacterial diseases. | Open | Open | 35 Gatehouse Drive | Waltham | MA | US | 02451 | Entasis Therapeutics | ||||
private:entasistx | 6453563 | Nov 16th, 2019 12:00AM | Entasis Therapeutics | 1.4K | 54.00 | Open | Biotechnology | Nov 16th, 2019 04:32PM | Nov 16th, 2019 04:32PM | Entasis Therapeutics is developing a portfolio of innovative cures for serious drug-resistant bacterial infections, a global health crisis affecting the lives of millions of patients. Our deep pipeline of novel clinical and preclinical antibacterial programs is designed to revolutionize the way physicians treat serious bacterial diseases. | Open | Open | 35 Gatehouse Drive | Waltham | MA | US | 02451 | Entasis Therapeutics | ||||
private:entasistx | 6453563 | Nov 15th, 2019 12:00AM | Entasis Therapeutics | 1.4K | 54.00 | Open | Biotechnology | Nov 15th, 2019 01:12PM | Nov 15th, 2019 01:12PM | Entasis Therapeutics is developing a portfolio of innovative cures for serious drug-resistant bacterial infections, a global health crisis affecting the lives of millions of patients. Our deep pipeline of novel clinical and preclinical antibacterial programs is designed to revolutionize the way physicians treat serious bacterial diseases. | Open | Open | 35 Gatehouse Drive | Waltham | MA | US | 02451 | Entasis Therapeutics | ||||
private:entasistx | 6453563 | Nov 13th, 2019 12:00AM | Entasis Therapeutics | 1.4K | 54.00 | Open | Biotechnology | Nov 13th, 2019 01:34PM | Nov 13th, 2019 01:34PM | Entasis Therapeutics is developing a portfolio of innovative cures for serious drug-resistant bacterial infections, a global health crisis affecting the lives of millions of patients. Our deep pipeline of novel clinical and preclinical antibacterial programs is designed to revolutionize the way physicians treat serious bacterial diseases. | Open | Open | 35 Gatehouse Drive | Waltham | MA | US | 02451 | Entasis Therapeutics | ||||
private:entasistx | 6453563 | Nov 12th, 2019 12:00AM | Entasis Therapeutics | 1.4K | 53.00 | Open | Biotechnology | Nov 12th, 2019 03:15PM | Nov 12th, 2019 03:15PM | Entasis Therapeutics is developing a portfolio of innovative cures for serious drug-resistant bacterial infections, a global health crisis affecting the lives of millions of patients. Our deep pipeline of novel clinical and preclinical antibacterial programs is designed to revolutionize the way physicians treat serious bacterial diseases. | Open | Open | 35 Gatehouse Drive | Waltham | MA | US | 02451 | Entasis Therapeutics | ||||
private:entasistx | 6453563 | Nov 11th, 2019 12:00AM | Entasis Therapeutics | 1.4K | 53.00 | Open | Biotechnology | Nov 11th, 2019 03:13PM | Nov 11th, 2019 03:13PM | Entasis Therapeutics is developing a portfolio of innovative cures for serious drug-resistant bacterial infections, a global health crisis affecting the lives of millions of patients. Our deep pipeline of novel clinical and preclinical antibacterial programs is designed to revolutionize the way physicians treat serious bacterial diseases. | Open | Open | 35 Gatehouse Drive | Waltham | MA | US | 02451 | Entasis Therapeutics | ||||
private:entasistx | 6453563 | Nov 10th, 2019 12:00AM | Entasis Therapeutics | 1.4K | 53.00 | Open | Biotechnology | Nov 10th, 2019 06:20PM | Nov 10th, 2019 06:20PM | Entasis Therapeutics is developing a portfolio of innovative cures for serious drug-resistant bacterial infections, a global health crisis affecting the lives of millions of patients. Our deep pipeline of novel clinical and preclinical antibacterial programs is designed to revolutionize the way physicians treat serious bacterial diseases. | Open | Open | 35 Gatehouse Drive | Waltham | MA | US | 02451 | Entasis Therapeutics | ||||
private:entasistx | 6453563 | Nov 9th, 2019 12:00AM | Entasis Therapeutics | 1.4K | 53.00 | Open | Biotechnology | Nov 9th, 2019 05:47PM | Nov 9th, 2019 05:47PM | Entasis Therapeutics is developing a portfolio of innovative cures for serious drug-resistant bacterial infections, a global health crisis affecting the lives of millions of patients. Our deep pipeline of novel clinical and preclinical antibacterial programs is designed to revolutionize the way physicians treat serious bacterial diseases. | Open | Open | 35 Gatehouse Drive | Waltham | MA | US | 02451 | Entasis Therapeutics | ||||
private:entasistx | 6453563 | Nov 8th, 2019 12:00AM | Entasis Therapeutics | 1.4K | 53.00 | Open | Biotechnology | Nov 8th, 2019 02:59PM | Nov 8th, 2019 02:59PM | Entasis Therapeutics is developing a portfolio of innovative cures for serious drug-resistant bacterial infections, a global health crisis affecting the lives of millions of patients. Our deep pipeline of novel clinical and preclinical antibacterial programs is designed to revolutionize the way physicians treat serious bacterial diseases. | Open | Open | 35 Gatehouse Drive | Waltham | MA | US | 02451 | Entasis Therapeutics |